XML 23 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Series A convertible redeemable preferred stock
Series B convertible redeemable preferred stock
Series C convertible redeemable preferred stock
Series D convertible redeemable preferred stock
Common Stock
Additional Paid-In Capital
Treasury Stock, at cost
Accumulated Deficit
Total
Balance at beginning of year at Dec. 31, 2013 $ 12,277 $ 49,376 $ 12,154   $ 1 $ 12,313 $ (3) $ (80,536)  
Balance at beginning of year at Dec. 31, 2013                 $ (68,225)
Balance at beginning of year (in shares) at Dec. 31, 2013         962,960        
Increase (decrease) in convertible redeemable preferred stock                  
Exercise of common stock options           72     72
Exercise of common stock options, shares         32,390        
Issuance of restricted stock awards to employees, shares         10,869        
Accruals of dividends and accretion to redemption value 504 1,836 960           3,300
Accruals of dividends and accretion to redemption value               (3,300) (3,300)
Stock-based compensation expense           22     22
Net loss               (17,917) (17,917)
Balance at end of year at Dec. 31, 2014 $ 12,781 $ 51,212 $ 13,114   $ 1 12,407 (3) (101,753)  
Balance at end of year at Dec. 31, 2014                 (89,348)
Balance at end of year (in shares) at Dec. 31, 2014 9,232,334 27,324,237 8,658,008   1,006,219        
Increase (decrease) in convertible redeemable preferred stock                  
Exercise of common stock options           517     517
Exercise of common stock options, shares         173,251        
Issuance of restricted stock awards to employees, shares         194,694        
Accruals of dividends and accretion to redemption value $ 2,297 $ 18,034 $ 2,996 $ 1,245         24,572
Accruals of dividends and accretion to redemption value           (24,572)     (24,572)
Exercise of warrants           6     6
Exercise of warrants (in shares)         16,062        
Issuance of convertible redeemable preferred stock, net of issuance costs       $ 44,807          
Issuance of convertible redeemable preferred stock, net of issuance costs, shares       37,500,000          
Conversion of notes to convertible redeemable preferred stock       $ 5,000          
Conversion of notes to convertible redeemable preferred stock, shares       4,166,667          
Extinguishment of prior preferred stock dividends (3,733) (23,341) (4,110)            
Extinguishment of prior preferred stock dividends           31,184     31,184
Conversion of preferred stock to common stock $ (11,345) $ (45,905) $ (12,000) $ (50,000) $ 13 119,237     119,250
Conversion of preferred stock to common stock, shares 9,232,334 27,324,237 8,658,008 41,666,667 12,591,463        
Public offering of common stock, net of issuance costs         $ 7 72,022     72,029
Public offering of common stock, net of issuance costs, shares         6,670,000        
Issuance of common stock in payment of accrued dividends       $ (1,052)   1,052     1,052
Issuance of common stock in payment of accrued dividends, shares         87,662        
Stock-based compensation expense           2,209     2,209
Net loss               (27,255) (27,255)
Balance at end of year at Dec. 31, 2015         $ 21 214,062 (3) (129,008)  
Balance at end of year at Dec. 31, 2015                 85,072
Balance at end of year (in shares) at Dec. 31, 2015         20,739,351        
Increase (decrease) in convertible redeemable preferred stock                  
Exercise of common stock options           443     443
Exercise of common stock options, shares         81,831        
Public offering of common stock, net of issuance costs         $ 8 137,332     137,340
Public offering of common stock, net of issuance costs, shares         8,500,000        
Issuance for employee stock purchase plan           442     442
Issuance for employee stock purchase plan, shares         42,918        
Retirement of treasury stock           (3) $ 3    
Stock-based compensation expense           5,787     5,787
Net loss               (94,176) (94,176)
Balance at end of year at Dec. 31, 2016         $ 29 $ 358,063   $ (223,184)  
Balance at end of year at Dec. 31, 2016                 $ 134,908
Balance at end of year (in shares) at Dec. 31, 2016         29,364,100